DD55956A - - Google Patents

Info

Publication number
DD55956A
DD55956A DD55956DA DD55956A DD 55956 A DD55956 A DD 55956A DD 55956D A DD55956D A DD 55956DA DD 55956 A DD55956 A DD 55956A
Authority
DD
German Democratic Republic
Application number
Publication of DD55956A publication Critical patent/DD55956A/xx

Links

DD55956D DD55956A (fr)

Publications (1)

Publication Number Publication Date
DD55956A true DD55956A (fr)

Family

ID=251922

Family Applications (1)

Application Number Title Priority Date Filing Date
DD55956D DD55956A (fr)

Country Status (1)

Country Link
DD (1) DD55956A (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (fr) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Procédé et dispositif pour la préparation de 5-méthyl-7-diéthylamino-s-triazolo[1,5-a]pyrimidine
WO2002002563A2 (fr) * 2000-06-30 2002-01-10 Wyeth Triazolopyrimidines substitues comme agents anticancereux
WO2004108136A1 (fr) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo`1,5-a!pyrimidines et leur utilisation en medecine
WO2005025315A1 (fr) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines permettant de combattre des parasites des animaux
WO2007062314A2 (fr) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Inhibiteurs de cetp heterocycliques
WO2008070496A2 (fr) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company Inhibiteurs d'amino cetp étendus
EP2392567A1 (fr) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Derives de benzothiazine et leurs utilisation comme modulateurs de lxr

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (fr) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Procédé et dispositif pour la préparation de 5-méthyl-7-diéthylamino-s-triazolo[1,5-a]pyrimidine
WO2002002563A2 (fr) * 2000-06-30 2002-01-10 Wyeth Triazolopyrimidines substitues comme agents anticancereux
WO2002002563A3 (fr) * 2000-06-30 2003-01-03 Wyeth Corp Triazolopyrimidines substitues comme agents anticancereux
AU2001273062B2 (en) * 2000-06-30 2005-11-24 Wyeth Substituted-triazolopyrimidines as anticancer agents
WO2004108136A1 (fr) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo`1,5-a!pyrimidines et leur utilisation en medecine
WO2005025315A1 (fr) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines permettant de combattre des parasites des animaux
EA010091B1 (ru) * 2003-09-12 2008-06-30 Басф Акциенгезельшафт 6-ГАЛОГЕНО[1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ ДЛЯ БОРЬБЫ С ВРЕДИТЕЛЯМИ
AU2004271715B2 (en) * 2003-09-12 2010-08-26 Basf Aktiengesellschaft 6-halogeno-(1,2,4)triazolo(1,5-a)pyrimidines for combating animal pests
EP2392567A1 (fr) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Derives de benzothiazine et leurs utilisation comme modulateurs de lxr
WO2007062314A2 (fr) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Inhibiteurs de cetp heterocycliques
WO2008070496A2 (fr) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company Inhibiteurs d'amino cetp étendus

Similar Documents

Publication Publication Date Title
AU2001273062B2 (en) Substituted-triazolopyrimidines as anticancer agents
AU2001273062A1 (en) Substituted-triazolopyrimidines as anticancer agents
US20070275961A1 (en) Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
ZA200602965B (en) 6-halogeno-[1,2,4]triazolo[1,5-A]pyrimidines for combating animal pests
DD55956A (fr)